Suscribirse

Implementing a clinical decision support tool to increase early peanut introduction guidance - 03/10/24

Doi : 10.1016/j.jaci.2024.07.005 
Annabelle F. Rowland, MD a, Thinh H. Nguyen, MD, PhD b, Priscila P. Cunha, MD a, Idil Ezhuthachan, MD a, Evan Orenstein, MD a, c, Swaminathan Kandaswamy, PhD a, Tricia Lee, MD a, d,
a Department of Pediatrics, Emory University School of Medicine, Atlanta, Ga 
b Division of Immunology, Boston Children's Hospital, Boston, Mass 
c Division of Hospital Medicine, Children's Healthcare of Atlanta, Atlanta, Ga 
d Children's Healthcare of Atlanta, Atlanta, Ga 

Corresponding author: Tricia Lee, MD, Division of Allergy/Immunology at Emory University and Children’s Healthcare of Atlanta, 100 Woodruff Circle, Atlanta, GA 30322.Division of Allergy/Immunology at Emory University and Children’s Healthcare of Atlanta100 Woodruff CircleAtlantaGA30322

Abstract

Background

General pediatric providers are the front line for early peanut introduction discussions, but many providers believe that they are ill-equipped to handle such discussions, as the guidelines have changed quickly.

Objective

We hypothesized that a clinical decision support (CDS) tool could improve discussions of peanut introduction.

Methods

CDS tools were designed by stakeholders, improved through usability testing, and integrated into the current note templates. On the basis of queries of electronic health records, we did a preperformance versus postperformance evaluation of conversations regarding peanut introduction, barriers to peanut introduction, and percentage of 12-month well-child checkups (WCCs) that resulted in successful introduction of peanut. Providers completed surveys before and after intervention to assess their awareness of early peanut introduction and comfort using the CDS tools.

Results

Providers’ awareness of early peanut introduction guidelines increased from 17.8% to 66.7% after the CDS tool was implemented; 79.1% of the providers were comfortable using the tool. The CDS tool improved peanut introduction conversations at the 4-month WCC from 2.4% to 81.2%, at the 6-month WCC from 3.0% to 84.2%, and at the 12-month WCC from 2.7% to 82.9%. In all, 56.6% of families had a plan to introduce peanut at the 4-month WCC. Of those who did not have a plan, the most common barrier was the family's unawareness of the benefits of early peanut introduction. At the 12-month WCC, 62.8% of families had introduced peanut without concerns.

Conclusion

A point-of-care CDS tool encouraged more discussions of early peanut introduction between general pediatric providers and all patients. CDS tools should be considered in quality improvement projects as an implementation method for the most up-to-date guidelines.

El texto completo de este artículo está disponible en PDF.

Key words : Allergy, clinical decision support, early peanut introduction, electronic health records, peanut, peanut introduction, simulation, user-centered design

Abbreviations used : AVS, CDS, EAI, EHR, LEAP, NIAID, WCC


Esquema


© 2024  American Academy of Allergy, Asthma & Immunology. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 154 - N° 4

P. 988 - octobre 2024 Regresar al número
Artículo precedente Artículo precedente
  • Single-cell RNA-sequencing of human eosinophils in allergic inflammation in the esophagus
  • Netali Ben-Baruch Morgenstern, Mark Rochman, Michael Kotliar, Julia L.M. Dunn, Lydia Mack, John Besse, Mia A. Natale, Andrea M. Klingler, Jennifer M. Felton, Julie M. Caldwell, Artem Barski, Marc E. Rothenberg
| Artículo siguiente Artículo siguiente
  • Leukotriene receptor antagonists as add-on therapy to antihistamines for urticaria: Systematic review and meta-analysis of randomized clinical trials
  • Daniel G. Rayner, Ming Liu, Alexandro W.L. Chu, Xiajing Chu, Gordon H. Guyatt, Paul Oykhman, Daniel J. Cao, Joseph Moellman, Moshe Ben-Shoshan, Diane R. Baker, Susan Waserman, David Lang, Javed Sheikh, Sameer K. Mathur, Lisa A. Beck, David A. Khan, Eric T. Oliver, Rachel N. Asiniwasis, Emily F. Cole, Kathryn E. Wheeler, Lauren Runyon, Jeffrey Chan, Kathryn P. Trayes, Sanaz Eftekhari, Donna D. Gardner, Tonya Winders, Sarbjit S. Saini, Jonathan A. Bernstein, Derek K. Chu

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.